𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Influence of P-glycoprotein on the transplacental passage of cyclosporine

✍ Scribed by P. Pávek; Z. Fendrich; F. štaud; J. Malákova; H. Brozmanová; M. LáznÍcek; V. Semecký; M. Grundmann; V. Palicka


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
243 KB
Volume
90
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis


The transfer kinetics of cyclosporine across the dually perfused rat placenta in the maternal to fetal direction and a possible involvement of P-glycoprotein were investigated. The transplacental clearance of cyclosporine in the materno±fetal direction was found to be dependent on the maternal in¯ow concentration of cyclosporine. Coadministration of cyclosporine with an excess of quinidine or chlorpromazine into the maternal compartment revealed 1.7-and 1.9-fold increase in cyclosporine concentration in the fetal compartment. In the experiments where quinidine was present both in the maternal and fetal compartments, cyclosporine appeared in the fetal compartment signi®cantly faster, and its amount was three times higher when compared with controls. Conversely, quinidine or chlorpromazine did not affect the transplacental passage of L-[ 3 H]-glucose. The interference of quinidine with the metabolism of cyclosporine in the placenta was excluded because only traces of M-1 and M-17 metabolites were found in the fetal solutions. Sodium azide, a mitochondrial respiratory inhibitor, was found to double the rate of cyclosporine, but not L-[ 3 H]glucose, passage across the placenta. Our ®ndings indicate that P-glycoprotein pumps cyclosporine out of the trophoblast cells of the rat placenta in the ATP-dependent manner and restricts the passage of cyclosporine across the placental barrier. ß 2001


📜 SIMILAR VOLUMES


The influence of expression of P-glycopr
✍ Jonathan K. Tunggal; Tricia Melo; James R. Ballinger; Ian F. Tannock 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 191 KB

The success of chemotherapy in the treatment of solid tumours may be limited by cellular mechanisms leading to drug resistance and/or by the slow penetration of drugs through tissue, resulting in a steep concentration gradient from tumour blood vessels. One mechanism leading to the development of mu